Promises and challenges of anticancer drugs that target the epigenome
Inge Verbrugge, Ricky W Johnstone, Michael Bots
Epigenomics | FUTURE MEDICINE LTD | Published : 2011
Awarded by Dutch Cancer Society
Supported by the Dutch Cancer Society to Inge Verbrugge (NKI2009-4446) and Michael Bots (AMC2009-4457). Ricky W Johnstone is a Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC) and supported by NHMRC Program and Project Grants, the Susan G Komen Breast Cancer Foundation, the Prostate Cancer Foundation of Australia, Cancer Council Victoria, The Victorian Cancer Agency, The Leukemia Foundation of Australia, Victorian Breast Cancer Research Consortium and the Australian Rotary Health Foundation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.